Ping‐Chih Hsu
Impact in
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 38
- Lung Cancer Diagnosis and Treatment 6
- Gastric Cancer Management and Outcomes 5
- Oncology 29
- Lung Cancer Research Studies 11
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 7
- Cancer Cells and Metastasis 3
- Co-authors
- Cheng‐Ta Yang (52 shared papers)David M. Jablons (12 shared papers)Liang You (12 shared papers)Yi‐Lin Yang (9 shared papers)Chih‐Hsi S. Kuo (40 shared papers)Zhidong Xu (8 shared papers)Yuyuan Dai (6 shared papers)Yueh‐Fu Fang (24 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (5 papers)Cancers (5 papers)Oncotarget (4 papers)Biomedicines (3 papers)Therapeutic Advances in Medical Oncology (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ping‐Chih Hsu
66 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 61
- Cell Biology 351
- Oncology 378
- Pulmonary and Respiratory Medicine 417
- Cancer Research 89
- Molecular Biology 355
Countries citing papers authored by Ping‐Chih Hsu
This map shows the geographic impact of Ping‐Chih Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Chih Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Chih Hsu more than expected).
Fields of papers citing papers by Ping‐Chih Hsu
This network shows the impact of papers produced by Ping‐Chih Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Chih Hsu. The network helps show where Ping‐Chih Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping‐Chih Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 155 | |
| 2 | 2017 | 104 | |
| 3 | 2016 | 99 | |
| 4 | 2020 | 64 | |
| 5 | 2017 | 52 | |
| 6 | 2016 | 48 | |
| 7 | 2018 | 45 | |
| 8 | 2018 | 29 | |
| 9 | 2020 | 28 | |
| 10 | 2019 | 28 | |
| 11 | 2017 | 28 | |
| 12 | 2017 | 27 | |
| 13 | 2018 | 25 | |
| 14 | 2021 | 23 | |
| 15 | 2021 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2023 | 15 | |
| 18 | 2022 | 15 | |
| 19 | 2021 | 14 | |
| 20 | 2020 | 14 |
About Ping‐Chih Hsu
Ping‐Chih Hsu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cell Biology, Molecular Biology and Pathology and Forensic Medicine, having authored 70 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (11 papers), Hippo pathway signaling and YAP/TAZ (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cell Biology (351 citations), Oncology (378 citations), Pulmonary and Respiratory Medicine (417 citations), Cancer Research (89 citations) and Molecular Biology (355 citations). Ping‐Chih Hsu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Cheng‐Ta Yang, David M. Jablons, Liang You, Yi‐Lin Yang, Chih‐Hsi S. Kuo, Zhidong Xu, Yuyuan Dai, Yueh‐Fu Fang, Yucheng Wang and Bin Hu. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Cancers, Oncotarget, Biomedicines and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.